Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report

Abstract Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor. Nonetheless, several efficacious intraperitoneal chemotherapy regimens have recently been developed for patients with peritoneal metastas...

Full description

Saved in:
Bibliographic Details
Main Authors: Kozo Miyatani, Wataru Miyauchi, Yusuke Kono, Yuji Shishido, Joji Watanabe, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, Yoji Fukumoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Soichiro Honjo, Toshimichi Hasegawa, Yoshiyuki Fujiwara
Format: Article
Language:English
Published: Japan Surgical Society 2020-05-01
Series:Surgical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40792-020-00849-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395896564842496
author Kozo Miyatani
Wataru Miyauchi
Yusuke Kono
Yuji Shishido
Joji Watanabe
Takehiko Hanaki
Kyoichi Kihara
Tomoyuki Matsunaga
Manabu Yamamoto
Yoji Fukumoto
Naruo Tokuyasu
Shuichi Takano
Teruhisa Sakamoto
Soichiro Honjo
Toshimichi Hasegawa
Yoshiyuki Fujiwara
author_facet Kozo Miyatani
Wataru Miyauchi
Yusuke Kono
Yuji Shishido
Joji Watanabe
Takehiko Hanaki
Kyoichi Kihara
Tomoyuki Matsunaga
Manabu Yamamoto
Yoji Fukumoto
Naruo Tokuyasu
Shuichi Takano
Teruhisa Sakamoto
Soichiro Honjo
Toshimichi Hasegawa
Yoshiyuki Fujiwara
author_sort Kozo Miyatani
collection DOAJ
description Abstract Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor. Nonetheless, several efficacious intraperitoneal chemotherapy regimens have recently been developed for patients with peritoneal metastases. However, no study has investigated the effectiveness of intraperitoneal chemotherapy for metachronous peritoneal metastases from gastric cancer after curative surgery. Case presentation We herein report a case of a 65-year-old man who had metachronous peritoneal metastases from gastric cancer after curative total gastrectomy who had been successfully treated with intraperitoneal chemotherapy. One month after surgery, adjuvant chemotherapy with S-1 was initiated given a final pathological stage of IIIB (pT4aN2M0). However, during adjuvant chemotherapy 12 months after surgery, tumor marker levels, which had been within normal range before surgery, increased with abdominal contrast-enhanced computed tomography (CT) revealing pelvic ascites. Thereafter, staging laparoscopy was performed, and the patient was diagnosed with peritoneal recurrence of gastric cancer. Following staging laparoscopy, an intraperitoneal access port was subcutaneously implanted for subsequent intraperitoneal chemotherapy. Combined chemotherapy with intraperitoneal and intravenous administration of paclitaxel and oral S-1 was then provided. After one course of combined chemotherapy, peritoneal lavage cytology was negative for malignancy. CT showed gradually decreasing ascites, whereas tumor marker levels returned to normal. The patient continued chemotherapy without major side effects and remained progression-free for 33 months with 36 chemotherapy cycles. Conclusions A combination regimen including intraperitoneal chemotherapy could be a promising option for patients with peritoneal recurrence after gastric cancer surgery.
format Article
id doaj-art-e361df68f3224086bca4b9fbc8f7d60b
institution Kabale University
issn 2198-7793
language English
publishDate 2020-05-01
publisher Japan Surgical Society
record_format Article
series Surgical Case Reports
spelling doaj-art-e361df68f3224086bca4b9fbc8f7d60b2025-08-20T03:39:28ZengJapan Surgical SocietySurgical Case Reports2198-77932020-05-01611510.1186/s40792-020-00849-2Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case reportKozo Miyatani0Wataru Miyauchi1Yusuke Kono2Yuji Shishido3Joji Watanabe4Takehiko Hanaki5Kyoichi Kihara6Tomoyuki Matsunaga7Manabu Yamamoto8Yoji Fukumoto9Naruo Tokuyasu10Shuichi Takano11Teruhisa Sakamoto12Soichiro Honjo13Toshimichi Hasegawa14Yoshiyuki Fujiwara15Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineDivision of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of MedicineAbstract Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor. Nonetheless, several efficacious intraperitoneal chemotherapy regimens have recently been developed for patients with peritoneal metastases. However, no study has investigated the effectiveness of intraperitoneal chemotherapy for metachronous peritoneal metastases from gastric cancer after curative surgery. Case presentation We herein report a case of a 65-year-old man who had metachronous peritoneal metastases from gastric cancer after curative total gastrectomy who had been successfully treated with intraperitoneal chemotherapy. One month after surgery, adjuvant chemotherapy with S-1 was initiated given a final pathological stage of IIIB (pT4aN2M0). However, during adjuvant chemotherapy 12 months after surgery, tumor marker levels, which had been within normal range before surgery, increased with abdominal contrast-enhanced computed tomography (CT) revealing pelvic ascites. Thereafter, staging laparoscopy was performed, and the patient was diagnosed with peritoneal recurrence of gastric cancer. Following staging laparoscopy, an intraperitoneal access port was subcutaneously implanted for subsequent intraperitoneal chemotherapy. Combined chemotherapy with intraperitoneal and intravenous administration of paclitaxel and oral S-1 was then provided. After one course of combined chemotherapy, peritoneal lavage cytology was negative for malignancy. CT showed gradually decreasing ascites, whereas tumor marker levels returned to normal. The patient continued chemotherapy without major side effects and remained progression-free for 33 months with 36 chemotherapy cycles. Conclusions A combination regimen including intraperitoneal chemotherapy could be a promising option for patients with peritoneal recurrence after gastric cancer surgery.http://link.springer.com/article/10.1186/s40792-020-00849-2Gastric cancerPeritoneal metastasisPeritoneal recurrenceMetachronous peritoneal metastasisIntraperitoneal chemotherapyPaclitaxel
spellingShingle Kozo Miyatani
Wataru Miyauchi
Yusuke Kono
Yuji Shishido
Joji Watanabe
Takehiko Hanaki
Kyoichi Kihara
Tomoyuki Matsunaga
Manabu Yamamoto
Yoji Fukumoto
Naruo Tokuyasu
Shuichi Takano
Teruhisa Sakamoto
Soichiro Honjo
Toshimichi Hasegawa
Yoshiyuki Fujiwara
Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
Surgical Case Reports
Gastric cancer
Peritoneal metastasis
Peritoneal recurrence
Metachronous peritoneal metastasis
Intraperitoneal chemotherapy
Paclitaxel
title Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
title_full Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
title_fullStr Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
title_full_unstemmed Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
title_short Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
title_sort successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with s 1 chemotherapy a case report
topic Gastric cancer
Peritoneal metastasis
Peritoneal recurrence
Metachronous peritoneal metastasis
Intraperitoneal chemotherapy
Paclitaxel
url http://link.springer.com/article/10.1186/s40792-020-00849-2
work_keys_str_mv AT kozomiyatani successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT watarumiyauchi successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT yusukekono successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT yujishishido successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT jojiwatanabe successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT takehikohanaki successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT kyoichikihara successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT tomoyukimatsunaga successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT manabuyamamoto successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT yojifukumoto successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT naruotokuyasu successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT shuichitakano successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT teruhisasakamoto successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT soichirohonjo successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT toshimichihasegawa successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport
AT yoshiyukifujiwara successfultreatmentofperitonealrecurrenceaftergastriccancersurgerywithintravenousandintraperitonealpaclitaxelcombinedwiths1chemotherapyacasereport